Jie Fan

Prof. Dr. Jie Fan


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JMJian Ma
Jian Ma
JPJingtao Peng
Jingtao Peng
RMRen Mo
Ren Mo
SMShaofei Ma
Shaofei Ma
JWJing Wang
Jing Wang
JFJie Fan
Jie Fan

1 December 2015 in Cancer Letters
Verified
Journal Article
Closed access
JPJingtao Peng
Jingtao Peng
JMJian Ma
Jian Ma
WLWeiguo Li
Weiguo Li
RMRen Mo
Ren Mo
PZPingzhao Zhang
Pingzhao Zhang
JFJie Fan
Jie Fan

8 May 2015 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
JPJingtao Peng
Jingtao Peng
RMRen Mo
Ren Mo
JMJian Ma
Jian Ma
JFJie Fan
Jie Fan
Renal cell carcinoma (RCC) is characterized by inherent resistance to chemotherapy. Earlier studies demonstrated that microRNAs (miRNAs) might be involved in the chemosensitivity of cancers. MicroRNA let-7, a putative tumor suppressor, is dysregulated in many cancers. Our study aims to investigate the exact role of let-7 in chemotherapy sensitivity of 5-fluorouracil (5-FU) in RCC. The clinical significance of let-7b and let-7c expression in surgically resected specimens was assessed by qRT-PCR. Cell proliferation assay and colony formation assay were used to assess the survival of 786-O cells treated with let-7b or let-7c combined with 5-FU. Western blot was used to detect the expression of Akt2 and caspase-7. Luciferase assay was used to detect the direct binding of let-7b and let-7c to the 3′-untranslated region (UTR) of Akt2. Expression of let-7b and let-7c was significantly decreased in 32 paired clear cell renal cell carcinoma tissue specimens and the dysregulation of let-7b was associated with pathological grade. Transfection of let-7b or let-7c combined with 5-FU inhibited proliferation and potentiated the antitumor efficacies of 5-FU at tolerated concentration. let-7b and let-7c suppressed the luciferase activity of reporter plasmid containing the 3′-UTR of Akt2. Overexpression of let-7b and let-7c reduced Akt2 expression, and Akt2 inhibition enhanced the sensitivity to 5-FU by affecting apoptotic pathway. Expression of let-7b and let-7c was frequently decreased in clear cell renal cell carcinoma tissues. The dysregulation of let-7b and let-7c may be involved in chemoresistance of RCC cells to 5-FU by down-regulating Akt2.

27 December 2011 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
LZLibin Zhou
Libin Zhou
BYBingde Yin
Bingde Yin
YLYongchao Liu
Yongchao Liu
YHYan Hong
Yan Hong
CZChangcun Zhang
Changcun Zhang
JFJie Fan
Jie Fan

1 January 2018
Verified
Journal Article
Closed access
JXJiantao Xiao
Jiantao Xiao
QSQing Shi
Qing Shi
WLWeiguo Li
Weiguo Li
XMXingyu Mu
Xingyu Mu
JPJintao Peng
Jintao Peng
JFJie Fan
Jie Fan

4 March 2014 in Oncology Letters
Verified
Journal Article
Open access
PDF file
CZChangcun Zhang
Changcun Zhang
RMRen Mo
Ren Mo
BYBinde Yin
Binde Yin
LZLibin Zhou
Libin Zhou
YLYongchao Liu
Yongchao Liu
JFJie Fan
Jie Fan
MicroRNA‑34a (miR‑34a) is a tumor suppressive microRNA, which induces G1 arrest, apoptosis and senescence by repressing the expression of multiple oncogenes. This study aimed to investigate the biological function and molecular mechanisms of miR‑34a in human renal cell carcinoma (RCC) cells. Quantitative polymerase chain reaction (qPCR) revealed that miR‑34a expression was significantly downregulated in eight of the 10 (80%) RCC tissues compared with adjacent normal tissues. In RCC cell lines, several other target genes of miR‑34a were dysregulated at the mRNA level when the expression of miR‑34a was elevated. In addition, western blot analysis and qPCR revealed that forced expression of miR‑34a downregulated the expression of Notch1 at the protein and mRNA level. The Cell Counting Kit‑8 identified that transient forced expression of miR‑34a inhibited cell growth and resulted in cell cycle arrest, which was evaluated by flow cytometry. Our data demonstrated that miR‑34a inhibits cell proliferation by downregulating Notch1 in RCC cell lines.